Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 09, 2022

SELL
$0.83 - $21.25 $37,921 - $970,870
-45,688 Reduced 36.8%
78,454 $51,000
Q2 2022

Aug 10, 2022

SELL
$1.12 - $2.18 $14,797 - $28,802
-13,212 Reduced 9.62%
124,142 $160,000
Q1 2022

May 10, 2022

BUY
$1.63 - $3.63 $47,822 - $106,500
29,339 Added 27.16%
137,354 $368,000
Q4 2021

Feb 04, 2022

BUY
$2.25 - $4.11 $138,069 - $252,206
61,364 Added 131.54%
108,015 $243,000
Q3 2021

Nov 05, 2021

BUY
$2.71 - $5.9 $126,424 - $275,240
46,651 New
46,651 $188,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track Boston Partners Portfolio

Follow Boston Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Partners, based on Form 13F filings with the SEC.

News

Stay updated on Boston Partners with notifications on news.